Powering Next-Generation Research with Precision-Grade Peptide Solutions.

Take weight loss to a new, sustainable, level with Peak Vitality’s Retatrutide. Unlike many single-hormone drugs, which only cause a decreased appetite, Retatrutide is a triple agonist, reducing appetite, improving insulin response, and increasing energy expenditure. The ultimate peptide for greater and more sustainable weight loss, improved blood sugar control, and better overall metabolic health.

KEY FACTORS:

• Triggers GLP-1 activity to reduce appetite
• Activates glucagon receptors to increase energy expenditure and fat breakdown
• Aids in significant weight loss and improved metabolic health, with the insulin-stimulating effects

WHAT IS RETATRUTIDE?

Retatrutide is a single molecule that activates the body’s receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. It reduces appetite and slows gastric emptying through GLP-1 activity, enhances insulin secretion and glucose control via both GLP-1 and GIP signaling, and uniquely increases energy expenditure and fat breakdown by activating glucagon receptors in the liver and adipose tissue.

DISCLAIMER

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Peak Vitality peptides have not been approved by Health Canada. Products by Peak Vitality have not been assessed for safety, efficacy and/or quality, may pose a range of serious health risks, and are intended for research purposes only. Products sold under Peak Vitality are not intended to treat, cure, or prevent diseases and/or conditions and may cause serious side effects.